To mimic genetic alterations typical for the majority of ALS-FUS cases, cell lines with the deletion of genomic sequences encoding the 12 C-terminal amino acids of FUS were produced using CRISPR/Cas9 editing. The gene discussed is FUS; the disease is amyotrophic lateral sclerosis.